Evolus (NASDAQ: EOLS) reported Q4 EPS of ($0.21), $0.09 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $60.99 million versus the consensus estimate of $60.19 million.

GUIDANCE:

Evolus sees FY2024 revenue of $255-265 million, versus the consensus of $263.5 million.

For earnings history and earnings-related data on Evolus (EOLS) click here.